CVE-2022-26389

Improper Access Control Vulnerability in ELI Electrocardiograph Devices

CVSS 7.7 HIGHEPSS 0.3%CWE-284

Vexday Risk Score

21Low

SSVC decision (CISA)

Track

No exploitation signal → monitor

CVSS 7.7EPSS 0.3%KEV nãoPoC —Nuclei —Metasploit —Patch —

Lifecycle

07 Feb 2025Published on NVD

Recommendation: Monitor — no exploitation signal at the moment.

An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H

Affected products

Baxter/ Hillrom · ELI 380 Resting Electrocardiograph Welch Allyn · ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph Welch Allyn · ELI 250c/BUR 250c Resting Electrocardiograph Welch Allyn · ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph

Want to know if your infrastructure is exposed to this?

Talk to TrueHacking →

References

https://hillrom.com/en/responsible-disclosures/https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-167-01